Skip to content

Tenoxicam

MUSCULO-SKELETAL SYSTEM

Also known as: mobiflex

YEAR INTRODUCED approvedATC M01AC02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Tenoxicam is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1987. DrugCentral lists 2 molecular targets, including PTGS1 and PTGS2. Recorded indications include Arthritis.

  • Molecular targets: PTGS1 and PTGS2 (2 listed in DrugCentral).
  • Indications: Arthritis.
  • ATC code: M01AC02 (Oxicams).
  • Molecular formula: C13H11N3O4S2; molecular weight 337.38 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Arthritis

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Prostaglandin G/H synthase 1PTGS1unknownIC50 5.94
Prostaglandin G/H synthase 2PTGS2unknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1987-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
M01AC02MUSCULO-SKELETAL SYSTEM › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS › Oxicams

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Tenoxicam is on its molecule page.

Molecular formulaC13H11N3O4S2
Molecular weight337.38 g/mol
CAS number—
InChIKeyLZNWYQJJBLGYLT-UHFFFAOYSA-N
PubChem CID54677971
CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=CS2)S1(=O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Tenoxicam used for?

DrugCentral lists the following indications for Tenoxicam: Arthritis.

How does Tenoxicam work?

Its molecular targets in DrugCentral include PTGS1 and PTGS2.

When was Tenoxicam first approved?

Tenoxicam was first approved by the YEAR INTRODUCED in 1987.

What is the chemical formula of Tenoxicam?

Tenoxicam has the molecular formula C13H11N3O4S2 and a molecular weight of 337.38 g/mol.

Browse: all drugs starting with T · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1987-01-01
AgencyYEAR INTRODUCED
Targets2
Indications1
FormulaC13H11N3O4S2
DrugCentral ID2595
Interactive profile